Peer-reviewedLicence not statedJAMA Dermatology
Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis
5 affiliations
- 1Medical College of Georgia, Augusta
- 2Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts
- 3Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts
- 4Harvard Medical School, Boston, Massachusetts
- 5Department of Dermatology, Massachusetts General Hospital, Boston
Related
- Systemic Retinoids in Cutaneous T-Cell Lymphoma: A Scoping Review of Clinical Use and Evidence Gaps
- Newly diagnosed and relapsed follicular lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.
- Development and validation of a model using routine clinical features to improve diabetes diagnosis.
- Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study
- Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma
BibTeX
@article{nayudu2026routine,
title = {{Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis}},
author = {Krithika Nayudu and Chirag Vasavda and Farrah Buckhoree and Thomas Kupper and Neda Shahriari and Steven Chen and Rachel Meltzer and Sasha Stephen and Cecilia Larocca},
journal = {JAMA Dermatology},
year = {2026},
month = nov,
doi = {10.1001/jamadermatol.2026.4305},
url = {https://doi.org/10.1001/jamadermatol.2026.4305},
}
RIS
TY - JOUR
TI - Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis
AU - Krithika Nayudu
AU - Chirag Vasavda
AU - Farrah Buckhoree
AU - Thomas Kupper
AU - Neda Shahriari
AU - Steven Chen
AU - Rachel Meltzer
AU - Sasha Stephen
AU - Cecilia Larocca
PY - 2026
DA - 2026/11/04
JO - JAMA Dermatology
DO - 10.1001/jamadermatol.2026.4305
UR - https://doi.org/10.1001/jamadermatol.2026.4305
SN - 2168-6068
SN - 2168-6084
ER -